Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM … P Bader, H Kreyenberg, GHR Henze, C Eckert, M Reising, A Willasch, ... Journal of Clinical Oncology 27 (3), 377-384, 2009 | 431 | 2009 |
How and when should we monitor chimerism after allogeneic stem cell transplantation? P Bader, D Niethammer, A Willasch, H Kreyenberg, T Klingebiel Bone marrow transplantation 35 (2), 107-119, 2005 | 294 | 2005 |
Ketoacidosis at onset of type 1 diabetes mellitus in children–frequency and clinical presentation A Neu, A Willasch, S Ehehalt, R Hub, MB Ranke, ... Pediatric diabetes 4 (2), 77-81, 2003 | 232 | 2003 |
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia IHIM Hollink, MM van den Heuvel-Eibrink, M Zimmermann, BV Balgobind, ... Blood, The Journal of the American Society of Hematology 113 (23), 5951-5960, 2009 | 159 | 2009 |
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending … P Bader, H Kreyenberg, A von Stackelberg, C Eckert, ... Journal of Clinical Oncology 33 (11), 1275-1284, 2015 | 147 | 2015 |
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation E Rettinger, AM Willasch, H Kreyenberg, A Borkhardt, W Holter, ... Blood, The Journal of the American Society of Hematology 118 (20), 5681-5688, 2011 | 135 | 2011 |
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells E Rettinger, S KuçI, I Naumann, P Becker, H Kreyenberg, M Anzaghe, ... Cytotherapy 14 (1), 91-103, 2012 | 133 | 2012 |
Continuous rise in incidence of childhood Type 1 diabetes in Germany S Ehehalt, G Blumenstock, AM Willasch, R Hub, MB Ranke, A Neu, ... Diabetic Medicine 25 (6), 755-757, 2008 | 109 | 2008 |
More precisely defining risk peri-HCT in pediatric ALL: pre-vs post-MRD measures, serial positivity, and risk modeling P Bader, E Salzmann-Manrique, A Balduzzi, JH Dalle, AE Woolfrey, M Bar, ... Blood advances 3 (21), 3393-3405, 2019 | 103 | 2019 |
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on … N Kröger, U Bacher, P Bader, S Böttcher, MJ Borowitz, P Dreger, I Khouri, ... Biology of Blood and Marrow Transplantation 16 (9), 1187-1211, 2010 | 101 | 2010 |
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation S Kuçi, E Rettinger, B Voß, G Weber, M Stais, H Kreyenberg, A Willasch, ... Haematologica 95 (9), 1579, 2010 | 98 | 2010 |
Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0–14 years of age A Neu, S Ehehalt, A Willasch, M Kehrer, R Hub, MB Ranke Diabetes care 24 (4), 785-786, 2001 | 89 | 2001 |
Epidemiological perspectives on type 1 diabetes in childhood and adolescence in Germany: 20 years of the Baden-Württemberg Diabetes Incidence Registry (DIARY) S Ehehalt, K Dietz, AM Willasch, A Neu, ... Diabetes care 33 (2), 338-340, 2010 | 82 | 2010 |
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study AM Willasch, B Gruhn, T Coliva, M Kalinova, G Schneider, H Kreyenberg, ... Leukemia 23 (8), 1472-1479, 2009 | 76 | 2009 |
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT … A Balduzzi, JH Dalle, K Jahnukainen, M von Wolff, G Lucchini, M Ifversen, ... Bone marrow transplantation 52 (10), 1406-1415, 2017 | 74 | 2017 |
Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia D Steinbach, P Bader, A Willasch, S Bartholomae, KM Debatin, ... Clinical Cancer Research 21 (6), 1353-1359, 2015 | 68 | 2015 |
Diabetes incidence in children of different nationalities: an epidemiological approach to the pathogenesis of diabetes A Neu, A Willasch, S Ehehalt, M Kehrer, R Hub, MB Ranke Diabetologia 44, B21-B26, 2001 | 66 | 2001 |
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL‐SCT 2003/2007 trial M Kuhlen, AM Willasch, JH Dalle, J Wachowiak, I Yaniv, M Ifversen, ... British journal of haematology 180 (1), 82-89, 2018 | 65 | 2018 |
Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells P Bader, J Soerensen, A Jarisch, E Ponstingl, T Krenn, J Faber, M Dürken, ... Best practice & research Clinical haematology 24 (3), 331-337, 2011 | 65 | 2011 |
Real-time PCR quantification of major Wilms’ tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences K Kramarzova, J Stuchly, A Willasch, B Gruhn, J Schwarz, J Cermak, ... Leukemia 26 (9), 2086-2095, 2012 | 59 | 2012 |